Statins and transcriptional regulation: The FXR connection

Biochemical and Biophysical Research Communications

Volumn 334, Issue 2, 2005, Pages 601-605

  Habeos, Ioannis ^a   Ziros, Panos G ^a   Psyrogiannis, Agathoklis ^a   Vagenakis, Apostolos G ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

DNA binding; Farnesoid X receptor; Gene expression; Lipoprotein metabolism; Simvastatin

Indexed keywords

CARBOHYDRATE; FARNESOID X RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; SIMVASTATIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HAMSTER; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

ADMINISTRATION, ORAL; ANIMALS; CELL LINE; CELLS, CULTURED; CRICETINAE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEPATOCYTES; LIVER; MALE; MESOCRICETUS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIMVASTATIN; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA; MESOCRICETUS AURATUS;

EID: 22144432245     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.06.129     Document Type: Article

References (21)

1. J.K. Liao Isoprenoids as mediators of the biological effects of statins J. Clin. Invest. 110 2002 285 288
2. B.M. Forman, E. Goode, J. Chen, A.E. Oro, D.J. Bradley, T. Perlmann, D.J. Noonan, L.T. Burka, T. McMorris, W.W. Lamph, R.M. Evans, and C. Weinberger Identification of a nuclear receptor that is activated by farnesol metabolites Cell 81 1995 687 693
3. J.Y. Chiang Bile acid regulation of gene expression: roles of nuclear hormone receptors Endocr. Rev. 23 2002 443 463
4. D.J. Parks, S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, S.A. Kliewer, J.B. Stimmel, T.M. Willson, A.M. Zavacki, D.D. Moore, and J.M. Lehmann Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
5. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
6. M. Watanabe, S.M. Houten, L. Wang, A. Moschetta, D.J. Mangelsdorf, R.A. Heyman, D.D. Moore, and J. Auwerx Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J. Clin. Invest. 113 2004 1408 1418
7. G. Lambert, M.J. Amar, G. Guo, H.B. Brewerr Jr., F.J. Gonzalez, and C.J. Sinal The farnesoid X-receptor is an essential regulator of cholesterol homeostasis J. Biol. Chem. 278 2003 2563 2570
8. Y. Zhang, L.W. Castellani, C.J. Sinal, F.J. Gonzalez, and P.A. Edwards Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR Genes Dev. 18 2004 157 169
9. D. Duran-Sandoval, B. Cariou, J.C. Fruchart, and B. Staels Potential regulatory role of the farnesoid X receptor in the metabolic syndrome Biochimie 87 2005 93 98
10. P.G. Ziros, A.P. Gil, T. Georgakopoulos, I. Habeos, D. Kletsas, E.K. Basdra, and A.G. Papavassiliou The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells J. Biol. Chem. 277 2002 23934 23941
11. M.S. Kim, J. Shigenaga, A. Moser, K. Feingold, and C. Grunfeld Repression of farnesoid X receptor during the acute phase response J. Biol. Chem. 278 2003 8988 8995
12. G. Martin, H. Duez, C. Blanquart, V. Berezowski, P. Poulain, J.C. Fruchart, J. Najib-Fruchart, C. Glineur, and B. Staels Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I J. Clin. Invest. 107 2001 1423 1432
13. G. Xu, L.X. Pan, H. Li, B.M. Forman, S.K. Erickson, S. Shefer, J. Bollineni, A.K. Batta, J. Christie, T.H. Wang, J. Michel, S. Yang, R. Tsai, L. Lai, K. Shimada, G.S. Tint, and G. Salen Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits J. Biol. Chem. 277 2002 50491 50496
14. J.L. Lew, A. Zhao, J. Yu, L. Huang, N. De Pedro, F. Pelaez, S.D. Wright, and J. Cui The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion J. Biol. Chem. 279 2004 8856 8861
15. P. Fan, B. Zhang, S. Kuroki, and K. Saku Pitavastatin, a potent hydroxymethylglutaryl coenzyme a reductase inhibitor, increases cholesterol 7 alpha-hydroxylase gene expression in HepG2 cells Circ. J. 68 2004 1061 1066
16. W.M. Pandak, D.M. Heuman, P.B. Hylemon, and Z.R. Vlahcevic Regulation of bile acid synthesis. IV. Interrelationship between cholesterol and bile acid biosynthesis pathways J. Lipid Res. 31 1990 79 90
17. R.P. Naoumova, F.H. O'Neill, S. Dunn, C.K. Neuwirth, G.W. Taylor, M. Axelson, and G.R. Thompson Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway Eur. J. Clin. Invest. 29 1999 404 412
18. T. Aoki, H. Yamazaki, T. Maejima, F. Sato, M. Kitahara, and Y. Saito Effect of pitavastatin on sterol and bile acid excretion in guinea pigs Arzneimittelforschung 53 2003 351 356
19. I. Bjorkhem Effects of mevinolin in rat liver: evidence for a lack of coupling between synthesis of hydroxymethylglutaryl-CoA reductase and cholesterol 7 alpha-hydroxylase activity Biochim. Biophys. Acta 877 1986 43 49
20. T. Clerc, V. Sbarra, N. Diaconescu, H. Lafont, G. Jadot, C. Laruelle, and F. Chanussot Effect of crilvastatin, a new cholesterol lowering agent, on unesterified LDL-cholesterol metabolism into bile salts by rat isolated hepatocytes Br. J. Pharmacol. 114 1995 624 631
21. T. Clerc, V. Sbarra, N. Domingo, J.P. Rault, N. Diaconescu, V. Moutardier, N. Hasselot, H. Lafont, G. Jadot, C. Laruelle, and F. Chanussot Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture Br. J. Pharmacol. 118 1996 1862 1868